Literature DB >> 15285525

Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment.

L Benazzato1, R D'Incà, F Grigoletto, E Perissinotto, V Medici, I Angriman, G C Sturniolo.   

Abstract

BACKGROUND: Severe attacks of ulcerative colitis have a high risk of colectomy. AIMS: To evaluate the effects of standard medical management and to identify the clinical and laboratory variables capable of predicting the clinical outcome.
MATERIALS AND METHODS: Prospective study monitoring the clinical and laboratory variables in 67 patients with severe colitis. Therapy consisted of prednisone, cyclosporin if no response, and azathioprine for maintenance. End-points were colectomy or remission. Logistic regression analysis was applied for statistical evaluation.
RESULTS: Fourteen (20%) patients required colectomy, 34 (50%) patients achieved remission with steroids, 25 (37%) patients received cyclosporin, 19 (76%) with benefit. Increased body temperature, pulse rate, sedimentation rate and C-reactive protein levels on admission were significantly associated with colectomy. Sedimentation rate greater than 75 mm/h and body temperature exceeding 38 degrees C at admission had 4.6- and 8.8-fold increased risk of colectomy. Less than 40% reduction in the bowel movements within 5 days predicted no response to steroids. Azathioprine maintained remission in 70% of the patients.
CONCLUSIONS: Elevated sedimentation rate and fever at day 1 best predict colectomy in severe colitis. Less than 40% reduction in the bowel movements at day 5 predicts no response to steroids. Cyclosporin has a high rate of success in acute attacks and azathioprine in maintaining remission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285525     DOI: 10.1016/j.dld.2003.12.017

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  12 in total

1.  Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.

Authors:  Han Ho Jeon; Hyun Jung Lee; Hui Won Jang; Jin Young Yoon; Yoon Suk Jung; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 2.  Acute severe ulcerative colitis: from pathophysiology to clinical management.

Authors:  Pieter Hindryckx; Vipul Jairath; Geert D'Haens
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-01       Impact factor: 46.802

3.  Management of acute colitis and toxic megacolon.

Authors:  Scott A Strong
Journal:  Clin Colon Rectal Surg       Date:  2010-12

4.  Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis.

Authors:  Taku Kobayashi; Makoto Naganuma; Susumu Okamoto; Tadakazu Hisamatsu; Nagamu Inoue; Hitoshi Ichikawa; Tetsuro Takayama; Riko Saito; Tomohisa Sujino; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-07-08       Impact factor: 7.527

5.  Predictors of clinical response to systemic steroids in active ulcerative colitis.

Authors:  Isabel Bernal; Míriam Mañosa; Eugeni Domènech; Esther Garcia-Planella; Mercè Navarro; Vicente Lorenzo-Zúñiga; Eduard Cabré; Miquel Angel Gassull
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

6.  Clinical manifestations and outcomes in severe ulcerative colitis.

Authors:  Xuesong Yang; Wei Yao; Wenbin Liu; Jun Li; Yumin Lu
Journal:  Front Med China       Date:  2007-05

Review 7.  Steroid-refractory severe ulcerative colitis: what are the available treatment options?

Authors:  Alan C Moss; Mark A Peppercorn
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Acute severe ulcerative colitis: latest evidence and therapeutic implications.

Authors:  Parambir S Dulai; Vipul Jairath
Journal:  Ther Adv Chronic Dis       Date:  2017-11-24       Impact factor: 5.091

9.  Infliximab to treat severe ulcerative colitis.

Authors:  Dídia Bisamra Cury; Marcelo de Souza Cury; Geraldo Vinicius Hemerly Elias; Sender Jankiel Mizsputen
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

Review 10.  Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Authors:  Shu-Chen Wei; Ting-An Chang; Te-Hsin Chao; Jinn-Shiun Chen; Jen-Wei Chou; Yenn-Hwei Chou; Chiao-Hsiung Chuang; Wen-Hung Hsu; Tien-Yu Huang; Tzu-Chi Hsu; Chun-Chi Lin; Hung-Hsin Lin; Jen-Kou Lin; Wei-Chen Lin; Yen-Hsuan Ni; Ming-Jium Shieh; I-Lun Shih; Chia-Tung Shun; Yuk-Ming Tsang; Cheng-Yi Wang; Horng-Yuan Wang; Meng-Tzu Weng; Deng-Chyang Wu; Wen-Chieh Wu; Hsu-Heng Yen; Jau-Min Wong
Journal:  Intest Res       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.